Cardiology in 2025: Year in Review

Cardiology has seen rapid evolution over the past year, between the constant advancement of GLP-1 receptor agonists and a series of rapid-fire approvals from the US Food and Drug Administration (FDA). Updated clinical guidelines on heart failure…